FINWIRES · TerminalLIVE
FINWIRES

Figma's Revenue Growth Accelerates on AI-Backed Offerings, Morgan Stanley Says

By

Figma (FIG) benefited from accelerating adoption of its AI-powered products in Q1, supporting seat expansion, paid customer conversion, and early credit monetization, Morgan Stanley said Friday in a report.

Revenue rose 46% from a year earlier, beating the market consensus even amid a "very dynamic competitive environment and a mixed macro backdrop," the report said.

Rising AI usage weighed on gross margins, which fell to around 82%, below Wall Street expectations of about 84%, the report said. Operating margins of 15.6% came in well ahead of consensus at 9%, and contracted by only 200 basis points, Morgan Stanley said.

Investors remain focused on issues including intensifying competition in design tools and uncertainty around the trajectory of Figma's gross margins, the report said. Still, Q1 results offered a "strong case" for the company's positioning in AI, Morgan Stanley said.

"Debates on the competitive dynamic and near-term margin pressures may limit upside in the shares without further data points from the company," the report said.

Morgan Stanley cut Figma's price target to $38 from $44 and maintained its equal-weight rating.

Price: $23.40, Change: $+3.16, Percent Change: +15.59%

Related Articles

Wire

Aardvark Therapeutics' Investigational New Drug Application for ARD-101 Put on Clinical Hold by FDA

Aardvark Therapeutics (AARD) said late Thursday the US Food and Drug Administration placed a full clinical hold on its investigational new drug application for ARD-101 to treat hyperphagia associated with Prader-Willi Syndrome.The hold applies to all ongoing clinical studies under the IND, the company said, adding that it is in discussions with the FDA for resolution of the clinical hold and to fix a path forward for the drug candidate.The company also plans to unblind clinical data from the HERO and OLE trials to assess the totality of efficacy and safety data, according to the company.The company said it had $91.2 million in cash and cash equivalents as of March 31, adequate to fund operations into mid-2027.

$AARD
Wire

Sky Harbour Q1 Loss Narrows, Revenue Rises; Shares Fall After Hours

Sky Harbour Group (SKYH) reported a Q1 loss late Thursday of $0.16 per diluted share, narrowing from a loss of $0.19 a year earlier.Analysts polled by FactSet expected a loss of $0.13.Revenue in the three months ended March 31 rose to $8.73 million from $5.59 million a year earlier.Analysts surveyed by FactSet expected $9.8 million.Sky Harbour shares fell 4.9% in after-hours trading.

$SKYH
Wire

KinderCare Learning Q1 Adjusted Earnings Fall, Revenue Rises; Shares Drop After Hours

KinderCare Learning (KLC) reported Q1 adjusted earnings late Thursday of $0.04 per diluted share, down from $0.23 a year earlier.Analysts surveyed by FactSet expected a loss of $0.01.Revenue in the three months ended April 4 rose to $672.5 million from $668.2 million a year earlier.Analysts surveyed by FactSet expected $669.1 million.The company boosted full-year adjusted EPS guidance to $0.15 to $0.25 from the previous forecast of $0.10 to $0.20. It affirmed the revenue outlook of $2.7 billion to $2.75 billion.Analysts expect EPS of $0.15 on revenue of $2.71 billion.KinderCare shares fell 6.2% in after-hours trading.

$KLC